To determine whether membrane-related events may be involved in attenuated luteal function after gonadotropin-releasing hormone (GnRH) administration, corpora lutea (CL) were removed from 10 beef heifers on day 7 of the estrous cycle after i.v. injection of GnRH or saline on day 2 of the cycle. Luteal slices were incubated with saline (control), luteinizing hormone (LH) or 8-bromo-cAMP for 2 h. In vivo administration of GnRH reduced LH and cAMP-stimulated progesterone production by tissue (p<0.01), but basal progesterone production was not affected (p>0.05). Luteal adenylyl cyclase activity did not differ between saline and GnRH-treated animals (p>0.05). Results of this experiment suggested that GnRH-induced alteration of bovine luteal function may be due to an effect distal to the point of cAMP accumulation. To explore further the effect of GnRH on luteal cell function, 10 heifers were injected with saline or GnRH and CL removed as above. Dissociated (mixed) and small luteal cells (SC) were cultured overnight, then incubated for 2 h with medium alone (control), LH or cAMP. In vitro treatment with LH and cAMP increased progesterone in the medium relative to controls (p<0.01), however, there was no effect of GnRH injection on progesterone production (p>0.05) nor in the percentage of large cells (LC) present in the mixed cell cultures (p=0.95). It has been previously found that the ratio of LC to SC increases in GnRH-treated animals. Many LC can be ruptured during dissociation of the CL, and it is possible that this procedure altered the number of LC, such that any differences that may have existed between the saline and GnRH-exposed CL were minimized. These data suggest that differences in the LC to SC ratio may indeed account for attenuated luteal function after exposure to GnRH. To examine if early administration of GnRH alters response of the CL to prostaglandin (PG) Fav beef heifers were injected with saline or GnRH on day 2 of the cycle (n=4/group), then injected with PGF[subscript 2��], on day 8 and the CL removed 60 min later. Blood samples were collected for oxytocin (OT) analysis at frequent intervals after PGF[subscript 2��], injection and for progesterone at 0 and 60 min. Induction of the early response gene c-jun or release of OT by PGF[subscript 2��], was not altered by GnRH injection (p>0.05). Injection of PGF[subscript 2��], decreased serum progesterone by 60 min post-injection (p<0.05), but was also unaffected by GnRH (p>0.05). These data support the hypotheses that c-jun expression and OT release are involved in PGF[subscript 2��]-induced luteolysis, but early administration of GnRH did not affect these processes. / Graduation date: 1996

Two studies were conducted to determine if 7-d MGA or PRID treatment initiated on d 17 of the estrous cycle altered: 1) follicular development, 2) estradiol-17β (E2) and progesterone (P4) concentrations, and 3) patterns of release of luteinizing hormone (LH). In both studies, Angus, Angus x Holstein or Holstein cows 2 to 6 yr of age were randomly assigned to receive either MGA (.5 mg⋅hd⁻¹⋅d⁻¹; n = 23) or PRID (n = 26) for 7 d or to serve as untreated controls (n = 14). Real time, B-mode ultrasound, equipped with a 7.5 mHz linear-array transrectal transducer, was used to conduct daily ovarian scans beginning 3 (Study 1) or 9 d (Study 2) after onset of estrus. Jugular venous blood samples (45 ml) were collected coincident with ovarian scans. In study 2, cows were fitted with indwelling jugular catheters 17 (Control, MGA and PRID), 20 and 23 d (MGA and PRID) after onset of estrus and blood samples were collected at 15-min intervals for 6 h for determination of LH. Interestrus interval was extended (P<.05) for 3 to 5 d in MGA-treated cows exhibiting two or three dominant follicles (classified as MGA-2 and MGA-3, respectively) or PRID-treated cows compared to controls exhibiting two or three dominant follicles during the estrous cycle (control-2 and control-3, respectively). Forty-four percent of MGA-treated cows ovulated the dominant follicle present at the beginning of MGA treatment. In both studies, days from detection of the ovulatory follicle until ovulation were greater (P<.01) in MGA-2 and control-2 cows than control-3, MGA-3 and PRID cows. Diameter of the ovulatory follicle was greater (P<.01) 9 d before estrus and growth rate of the ovulatory follicle was less (P<.02) in MGA-2 and control- 2 cows than control-3, MGA-3 and PRID cows. Serum P4 decreased 3 d earlier (P<.02) during the estrous cycle of MGA-2 and control-2 cows than control-3, MGA-3 and PRID cows. Serum E2 was greater (P<.01) 7 d before estrus in MGA-2 cows than all other treatment groups. Changes in mean and baseline LH concentrations and amplitude of LH pulses on d 17, 20 and 23 after onset of estrus did not differ (P>.10) among treatments. Luteinizing hormone pulse frequency was greater (P<.03) on d-20 after onset of estrus in MGA-2 cows than MGA-3 and PRID cows (4.3 ± .6 vs 2.6 ± .3 and 3.2 ± .4, respectively). In addition, LH pulse frequency did not differ (P>.10) 17 or 23 d after onset of estrus among treatments. In conclusion, MGA treatment extended the dominance phase of development of ovulatory follicles, which resulted in the premature increase in serum E2 and frequency of LH release, whereas the dominant follicle present at the beginning of PRID treatment underwent atresia and another preovulatory follicle developed. / Ph. D.